| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxel
|
Sams, L.
|
|
|
23 |
11 |
p. 2394-2401
|
artikel
|
| 2 |
A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients
|
Wang, K.
|
|
|
23 |
11 |
p. 2368-2381
|
artikel
|
| 3 |
Circular RNA hsa_circ_0091579 facilitates the Warburg effect and malignancy of hepatocellular carcinoma cells via the miR-624/H3F3B axis
|
Chen, Y.
|
|
|
23 |
11 |
p. 2280-2292
|
artikel
|
| 4 |
Circulating non-coding RNAs as new biomarkers and novel therapeutic targets in colorectal cancer
|
Yang, L.
|
|
|
23 |
11 |
p. 2220-2236
|
artikel
|
| 5 |
Comparative genomic characterization of melanoma of known and unknown primary
|
Rassy, E.
|
|
|
23 |
11 |
p. 2302-2308
|
artikel
|
| 6 |
COPB2: a transport protein with multifaceted roles in cancer development and progression
|
Feng, Y.
|
|
|
23 |
11 |
p. 2195-2205
|
artikel
|
| 7 |
Dosimetric impact of rectum and bladder anatomy and intrafractional prostate motion on hypofractionated prostate radiation therapy
|
Roch, M.
|
|
|
23 |
11 |
p. 2293-2301
|
artikel
|
| 8 |
HPV16 infection promotes an M2 macrophage phenotype to promote the invasion and metastasis of esophageal squamous cell carcinoma
|
Yuan, X.
|
|
|
23 |
11 |
p. 2382-2393
|
artikel
|
| 9 |
Mechanisms of primary and acquired resistance to PD-1/PD-L1 blockade and the emerging role of gut microbiome
|
Zou, R.
|
|
|
23 |
11 |
p. 2237-2252
|
artikel
|
| 10 |
microRNA-377-3p inhibits osteosarcoma progression by targeting CUL1 and regulating Wnt/β-catenin signaling pathway
|
Liang, K.
|
|
|
23 |
11 |
p. 2350-2357
|
artikel
|
| 11 |
MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer
|
Tang, J.
|
|
|
23 |
11 |
p. 2323-2334
|
artikel
|
| 12 |
PD-1 and PD-L1 gene expressions and their association with Epstein-Barr virus infection in chronic lymphocytic leukemia
|
Gamaleldin, M. A.
|
|
|
23 |
11 |
p. 2309-2322
|
artikel
|
| 13 |
Physio-pathological effects of m6A modification and its potential contribution to melanoma
|
Liao, Y.
|
|
|
23 |
11 |
p. 2269-2279
|
artikel
|
| 14 |
Saving time in the radiotherapy procedures for COVID-19 pneumonia treatment. A single-institution experience
|
Bonet, M.
|
|
|
23 |
11 |
p. 2344-2349
|
artikel
|
| 15 |
Sexual, bladder and bowel function following different minimally invasive techniques of radical hysterectomy in patients with early-stage cervical cancer
|
Baessler, K.
|
|
|
23 |
11 |
p. 2335-2343
|
artikel
|
| 16 |
Stance of MRD in Non-Hodgkin’s Lymphoma and its upsurge in the novel era of cell-free DNA
|
Garg, S.
|
|
|
23 |
11 |
p. 2206-2219
|
artikel
|
| 17 |
Targeting GLS1 to cancer therapy through glutamine metabolism
|
Yu, Wei
|
|
|
23 |
11 |
p. 2253-2268
|
artikel
|
| 18 |
5-year results of accelerated partial breast irradiation (APBI) with SBRT (stereotactic body radiation therapy) and exactrac adaptive gating (Novalis®) for very early breast cancer patients: was it all worth it?
|
Ciérvide, R.
|
|
|
23 |
11 |
p. 2358-2367
|
artikel
|
Tijdschrift beschrijving